BE889758A - Oxazolidine-2,4-diones substituees en position 5 a action hypoglycemique - Google Patents

Oxazolidine-2,4-diones substituees en position 5 a action hypoglycemique Download PDF

Info

Publication number
BE889758A
BE889758A BE0/205506A BE205506A BE889758A BE 889758 A BE889758 A BE 889758A BE 0/205506 A BE0/205506 A BE 0/205506A BE 205506 A BE205506 A BE 205506A BE 889758 A BE889758 A BE 889758A
Authority
BE
Belgium
Prior art keywords
emi
product
mixture
ethyl acetate
evaporated
Prior art date
Application number
BE0/205506A
Other languages
English (en)
French (fr)
Inventor
R C Schnur
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BE889758A publication Critical patent/BE889758A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/511—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
    • C07C45/513—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups the singly bound functional group being an etherified hydroxyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BE0/205506A 1980-07-28 1981-07-27 Oxazolidine-2,4-diones substituees en position 5 a action hypoglycemique BE889758A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17320680A 1980-07-28 1980-07-28

Publications (1)

Publication Number Publication Date
BE889758A true BE889758A (fr) 1982-01-27

Family

ID=22630977

Family Applications (2)

Application Number Title Priority Date Filing Date
BE0/205506A BE889758A (fr) 1980-07-28 1981-07-27 Oxazolidine-2,4-diones substituees en position 5 a action hypoglycemique
BE0/205505A BE889757A (fr) 1980-07-28 1981-07-27 Nouvelles oxazolidine -2,4- diones substituees en position 5 douees d'activite hypoglycemique

Family Applications After (1)

Application Number Title Priority Date Filing Date
BE0/205505A BE889757A (fr) 1980-07-28 1981-07-27 Nouvelles oxazolidine -2,4- diones substituees en position 5 douees d'activite hypoglycemique

Country Status (4)

Country Link
JP (1) JPS5758676A (es)
BE (2) BE889758A (es)
GT (2) GT198170554A (es)
ZA (2) ZA815126B (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0097453B1 (en) * 1982-06-23 1990-04-11 Pfizer Inc. Alicyclic substituted oxazolidine-2,4-diones having hypoglycemic activity

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4617312A (en) * 1983-01-17 1986-10-14 Pfizer Inc. Aldose reductase inhibiting 5-(2-alkoxyphenyl) thiazolidinediones

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0097453B1 (en) * 1982-06-23 1990-04-11 Pfizer Inc. Alicyclic substituted oxazolidine-2,4-diones having hypoglycemic activity

Also Published As

Publication number Publication date
ZA815133B (en) 1982-07-28
ZA815126B (en) 1983-02-23
GT198170555A (es) 1983-01-12
JPS5758676A (en) 1982-04-08
JPS6135188B2 (es) 1986-08-12
BE889757A (fr) 1982-01-27
GT198170554A (es) 1983-01-12

Similar Documents

Publication Publication Date Title
CH653025A5 (fr) Oxazolidine-2,4-diones substituees en position 5 douees d'activite hypoglycemique.
US4342771A (en) Hypoglycemic 5-substituted oxazolidine-2,4-diones
CH639974A5 (fr) Spiro-oxazolidine-diones.
LU83513A1 (fr) Procede de production d'oxazolidine-2,4-diones substituees en position 5
FR2657081A1 (fr) Nouveaux derives d'arylvinylamide, leur procede de fabrication et leur application en therapeutique.
EP0109866A1 (fr) Nouveaux dérivés de la sulfonylurée, leurs procédés de préparation et les compositions pharmaceutiques les renfermant
JPS5916881A (ja) 血糖低下活性を有する、脂環式置換されたオキサゾリジン−２，４−ジオン
CA2074365A1 (fr) Derives de l'uree, leur preparation et les medicaments les contenant
US4753956A (en) Hypoglycemic 5-substituted oxazolidine-2,4-diones
BE889758A (fr) Oxazolidine-2,4-diones substituees en position 5 a action hypoglycemique
CH622512A5 (es)
US4689336A (en) Hypoglycemic 5-substituted oxazolidine 2,4-diones
WO2007048986A1 (fr) Nouveau procede de preparation de sels d'acides et d'ammonium quaternaires
BE779775A (fr) Derives de l'uree, procede pour les preparer et leurs applications
EP0362006A1 (fr) Dérivés de quinoléine, leurs procédés de préparation et les médicaments les contenant
LU83511A1 (fr) Procede de preparation d'acides dialuriques substitues en position 5
US4565820A (en) Hypoglycemic 5-pyrrolyl, indolyl and quinolyl substituted oxazolidine-2,4-diones and their use
LU85296A1 (fr) Procede de preparation de derives de pyrimidinetrione
US4812471A (en) Hypoglycemic 5-(isoxazolyl or isothiazolyl)-oxazolidine-2,4-diones
CH648483A5 (fr) Composition pharmaceutique contre l'arthrite rhumatoide.
FR2471978A1 (fr) Nouvelles oxazolines
KR850000389B1 (ko) 5-치환된 옥사졸리딘-2, 4-디온의 제조방법
FR2489330A1 (fr) 6-alkyl-1, 2-dihydro-2-oxo-pyridines a substituant tetrazolyle ou carboxaldehyde en position 3 et composition pharmaceutique les contenant
BE884946A (fr) Acide aminobenzoique ou son derive comme infredient actif d'une composition pharmaceutique et composition pharmaceutique contenant un tel ingredient actif
LU85410A1 (fr) 1-phenoxy-3-hydroxyindolylalkylamino-3-propanols et leur preparation

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: PFIZER INC.

Effective date: 19900731